MedTrace Logo

SAS in Patients With Bronchial Carcinoma

NCT02270853 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-02-18

No results posted yet for this study

Summary

In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.

Conditions

  • Sleep Apnea Syndrome
  • Bronchial Carcinoma

Interventions

DEVICE

sleep apnea screening with ApneaLinkTM

ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Michael Dreher, Univ.-Prof. · RWTH Aachen University Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270853 on ClinicalTrials.gov